Picture of Biogen logo

BIIB Biogen Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapSuper Stock

Annual income statement for Biogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue12,27413,45314,37813,44510,982
Cost of Revenue
Gross Profit10,64411,63712,42311,6398,872
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses6,9307,5647,3358,8958,141
Operating Profit5,3445,8897,0434,5502,841
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes5,1295,9007,1265,0481,745
Provision for Income Taxes
Net Income After Taxes3,8444,4985,9684,0551,693
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Extraordinary Items
Net Income2,5394,4315,8894,0011,556
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income2,5394,4315,8894,0011,556
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS1823.632.625.914.6

Or unlock with your email

Or unlock with your email